Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures
| Status: | Withdrawn |
|---|---|
| Conditions: | Cancer, Cancer, Pancreatic Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 89 |
| Updated: | 2/15/2017 |
| Start Date: | October 2013 |
| End Date: | June 2015 |
The investigators hypothesis is that a 22 gauge needle can yield core tissue, obviating the
need to use the 19 gauge needle for core tissue procurement.
need to use the 19 gauge needle for core tissue procurement.
Inclusion Criteria
1. Age under 19 years
2. Pregnant women will be excluded. This will be confirmed by self-report
Exclusion Criteria
1. Age under 19 years
2. Pregnant women will be excluded. This will be confirmed by self-report
1. Age under 19 years
2. Pregnant women will be excluded. This will be confirmed by self-report
Exclusion Criteria
1. Age under 19 years
2. Pregnant women will be excluded. This will be confirmed by self-report
Inclusion Criteria:
- All patients who are referred to Florida Hospital Center for Interventional Endoscopy
for a EUS FNA for core biopsy (19 gauge needle biopsy) who have needle dysfunction
(This occurs in about 10% of patients)
Exclusion Criteria:
- Age under 19 years
- Pregnant women will be excluded. This will be confirmed by self-report
We found this trial at
1
site
Florida Hospital Florida Hospital is one of the country
Click here to add this to my saved trials
